Solara Active Pharma shares jump 5% as Q1 profit rises 55%; Ibuprofen business remains a drag

The company said its commodity Ibuprofen business continued to weigh on profitability, reporting another quarter of low gross margins and negative EBITDA.

Leave a Reply

Your email address will not be published. Required fields are marked *